AU Patent

AU2024252105A1 — Crystalline forms of ras inhibitors, compositions containing the same, and methods of use thereof

Assigned to Revolution Medicines Inc · Expires 2025-10-16 · 1y expired

What this patent protects

The disclosure features crystalline forms of Ras inhibitors, pharmaceutical compositions thereof, and their uses in the treatment of cancers.

USPTO Abstract

The disclosure features crystalline forms of Ras inhibitors, pharmaceutical compositions thereof, and their uses in the treatment of cancers.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024252105A1
Jurisdiction
AU
Classification
—
Expires
2025-10-16
Drug substance claim
No
Drug product claim
No
Assignee
Revolution Medicines Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.